| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8922531 | Clinical and Translational Radiation Oncology | 2016 | 8 Pages |
Abstract
The HPV status, CSC marker expression of CD44 and SLC3A2 as well as hypoxia status are potential prognostic biomarkers for patients with locally advanced HNSCC treated by postoperative radiotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Annett Linge, Steffen Löck, Constanze Krenn, Steffen Appold, Fabian Lohaus, Alexander Nowak, Volker Gudziol, Gustavo B. Baretton, Frank Buchholz, Michael Baumann, Mechthild Krause,